| 07.30.21 | Regeneron's antibody scores expanded FDA nod; AZ shots sent to Mexico, Canada without full review

Click here to subscribe to Fiercebiotech.com

3 years ago

Html
Text

The ‘war has changed’ against COVID To view this email as a web page, click here

September 28-30: Pennsylvania Convention Center, Philadelphia | October 5-8: Virtual Event

Through a series of keynote speakers, case studies, panel discussions and practical sessions featuring subject matter experts, #DPEast2021 will provide a cross section of strategies and best practices used by pharma companies and cover in-depth topics across the full value chain of life science marketing. Learn more.

Today's Rundown

With expanded FDA nod, Regeneron's COVID-19 antibody drug can help the immunocompromised U.S. sent Mexico and Canada AstraZeneca COVID-19 vaccines before fully vetting production site: report 53 health systems requiring mandatory COVID-19 vaccines for their workforces As Veklury's sales slide, Gilead hopes for a quicker rebound from Biktarvy, other HIV drugs COVID-19 tracker: CDC warns 'war has changed' with Delta variant; Japan to resume AZ jabs as cases climb Fierce Pharma Asia—AstraZeneca's China growth; Takeda's $3.5B neuro pact; Biocon, Viatris' historic biosimilar nod

Featured Story

With expanded FDA nod, Regeneron's COVID-19 antibody drug can help the immunocompromised

By Kevin Dunleavy

The FDA has expanded its EUA for Regeneron's COVID-19 drug as a preventative therapy for those who have been exposed to the disease and who are at high risk to progress to a severe case.

Whitepaper: Integrating Your IRB and IBC Processes to Improve and Accelerate Clinical Trials

The benefits of integrating IRB and IBC review processes were brought to light during the COVID pandemic. In this whitepaper learn about: an overview of the IRB and IBC, understanding the IBC process, advancing COVID-19 vaccine development through integrated reviews, and the future of gene therapy. Learn More.

U.S. sent Mexico and Canada AstraZeneca COVID-19 vaccines before fully vetting production site: report

By Kevin Dunleavy

The U.S. sent AstraZeneca COVID-19 vaccines to Mexico and Canada even though it had yet to sanction the plant where they were manufactured, Emergent's troubled facility in Baltimore.

53 health systems requiring mandatory COVID-19 vaccines for their workforces

By Dave Muoio

COVID-19 vaccination as a condition of employment has picked up the support of numerous industry and professional organizations. More health systems are taking a hard stance.

As Veklury's sales slide, Gilead hopes for a quicker rebound from Biktarvy, other HIV drugs

By Kevin Dunleavy

As the coronavirus pandemic subsides, so do the sales for Gilead's Veklury. The company now hopes for a corresponding improvement in the sales of its formidable HIV treatments.

COVID-19 tracker: CDC warns 'war has changed' with Delta variant; Japan to resume AZ jabs as cases climb

By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner

The CDC warned in internal presentations that the war against COVID-19 has changed because of the rapidly spreading Delta variant, the Washington Post reports. Japan will resume using AstraZeneca's jab following safety concerns as Tokyo reports record infections. And more headlines.

Fierce Pharma Asia—AstraZeneca's China growth; Takeda's $3.5B neuro pact; Biocon, Viatris' historic biosimilar nod

By Angus Liu

AstraZeneca expects slower growth from its China business moving forward. Takeda signed a neurodegenerative diseases R&D pact with PeptiDream worth up to $3.5 billion. Biocon and Viatris won the first FDA interchangeable biosimilar tag for their copy of Sanofi's Lantus. And more.

Webinar: Parkland's Transformation Journey Managing Real-Time Healthcare

Thursday, August 19 | 2pm ET / 11am PT

Parkland, the prestigious safety-net hospital serving Dallas County residents has the busiest emergency rooms in the US, with over 240,000 visits in 2019. Join our webinar to explore Parkland’s Health and Hospital System's transformation journey to managing real-time healthcare. Register Now.

Share on

Other newsletters from Fiercebiotech.com

More newsletters from Fiercebiotech.com

COVID-19 Tracker

Featured Story

With expanded FDA nod, Regeneron's COVID-19 antibody drug can help the immunocompromised

Top Stories

U.S. sent Mexico and Canada AstraZeneca COVID-19 vaccines before fully vetting production site: report

53 health systems requiring mandatory COVID-19 vaccines for their workforces

As Veklury's sales slide, Gilead hopes for a quicker rebound from Biktarvy, other HIV drugs

COVID-19 tracker: CDC warns 'war has changed' with Delta variant; Japan to resume AZ jabs as cases climb

Fierce Pharma Asia—AstraZeneca's China growth; Takeda's $3.5B neuro pact; Biocon, Viatris' historic biosimilar nod

| 07.30.21 | Regeneron's antibody scores expanded FDA nod; AZ shots sent to Mexico, Canada without full review

COVID-19 Tracker

Featured Story

With expanded FDA nod, Regeneron's COVID-19 antibody drug can help the immunocompromised

Top Stories

U.S. sent Mexico and Canada AstraZeneca COVID-19 vaccines before fully vetting production site: report

53 health systems requiring mandatory COVID-19 vaccines for their workforces

As Veklury's sales slide, Gilead hopes for a quicker rebound from Biktarvy, other HIV drugs

COVID-19 tracker: CDC warns 'war has changed' with Delta variant; Japan to resume AZ jabs as cases climb

Fierce Pharma Asia—AstraZeneca's China growth; Takeda's $3.5B neuro pact; Biocon, Viatris' historic biosimilar nod

Share on

Other newsletters from Fiercebiotech.com

Related newsletters